We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IVA:NASDAQInventiva S.A. - American Depository Shares analysis

Data as of Sep 23, 2026 - not real-time

Latest price
$3.53
Risk: high
9/10High risk

Summary

Inventiva S.A. is priced at $3.53 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 25.7%. RSI sits at 22.5, which reads as oversold, and MACD momentum is bearish. Watch $3.52 as support and $5.10 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 321.4% above the current price. Revenue is contracting at 89.9%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 37.3%, a beta of 1.28 and a maximum drawdown of 52.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top market events

  • Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients...
  • News zur INVENTIVA SA ADR AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ Stifel reiterates Buy on Inventiva stock, $15...
  • Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in...

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 22.5 signals oversold conditions
  • Trading below the 200-day average of 5.06

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 22.5 signals oversold conditions
  • Trading below the 200-day average of 5.06

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +321.4% versus the current price
  • Revenue contracting at -89.9%
  • Negative free cash flow

Key metrics

Financial health

Revenue Growth-89.90%
P/E Ratio-4.4
ROA-45.08%
P/B Ratio-20.6
Op. Cash Flow$-104884000
Free Cash Flow$-200711632
Industry P/E30.5

Technical analysis

TrendBearish
RSI22.5
Support$3.52
Resistance$5.10
MA 20$4.33
MA 50$4.48
MA 200$5.06
MACDBearish
VolumeIncreasing
Fear & Greed Index95.93

Valuation

Target Price$14.87
Upside/Downside321.36%
GradeFair
TypeBlend

Risk assessment

Beta1.28
Volatility37.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.